Clinical trial
Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women - A Randomized Trial
NCT04755517 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women - A Randomized Trial
- Lead sponsor
- Tampere University Hospital
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- June 9, 2020
- Completion date
- December 31, 2025
- Enrollment
- 14,000 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
adenocarcinoma in situ, cervical intraepithelial neoplasia grade 2/3